UroMems completes first-in-man enrollment for smart implant study
UroMems announced today that it successfully completed enrollment in its first-in-human study of its UroActive system.
Stay updated with breaking news from Pierre Mozer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UroMems announced today that it successfully completed enrollment in its first-in-human study of its UroActive system.
The CEO of UroMems shares the design and engineering story of the company's automated artificial urinary sphincter device.
The CEO of UroMems shares the design and engineering story of the company's automated artificial urinary sphincter device.
UroMems announced that it successfully met the primary endpoints for the initial male patient in a study of its UroActive smart implant.
/PRNewswire/ -- UroMems, a global company developing innovative, mechatronics technology to treat stress urinary incontinence (SUI), announced today that it...